A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

The purpose of this trial was to examine the efficacy of the addition of levamisole (LEV) or interferon alfa (IFN) to an adjuvant chemotherapy with 5-fluorouracil (5-FU) in patients with stage III colon cancer. According to a 2 × 2 factorial study design, 598 patients were randomly assigned to one o...

Descripción completa

Detalles Bibliográficos
Autores principales: Schippinger, W, Jagoditsch, M, Sorré, C, Gnant, M, Steger, G, Hausmaninger, H, Mlineritsch, B, Schaberl-Moser, R, Mischinger, H J, Hofbauer, F, Holzberger, P, Mittlböck, M, Jakesz, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362025/
https://www.ncbi.nlm.nih.gov/pubmed/15856042
http://dx.doi.org/10.1038/sj.bjc.6602555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362025/
https://www.ncbi.nlm.nih.gov/pubmed/15856042
http://dx.doi.org/10.1038/sj.bjc.6602555

Ejemplares similares